Supreme Court Asked To Take Up Lupron Labeling Suit

Law360, Chicago (November 1, 2013, 5:50 PM EDT) -- A Nevada woman on Thursday petitioned the U.S. Supreme Court for a new trial in her suit accusing TAP Pharmaceutical Products Inc. and Abbott Laboratories of failing to warn her about the risks of their drug Lupron, claiming a federal judge was biased against her and excluded important evidence.

Karin Klein claims the Ninth Circuit erred when it upheld a lower court’s decision to keep from a jury old labels for Lupron showing the companies had previously warned of bone density loss and thyroid problems in...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.